4//SEC Filing
Goddard Glenn 4
Accession 0000950170-24-025901
CIK 0001652130other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:10 PM ET
Size
7.0 KB
Accession
0000950170-24-025901
Insider Transaction Report
Form 4
Goddard Glenn
EVP, Chief Financial Officer
Transactions
- Award
Common Stock
2024-03-01+28,628→ 69,213 total - Award
Stock Option (right to buy)
2024-03-01+41,316→ 41,316 totalExercise: $32.66Exp: 2034-02-28→ Common Stock (41,316 underlying)
Footnotes (2)
- [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
- [F2]This option was granted on March 1, 2024 with respect to shares of Common Stock, with 33% vesting on January 1, 2025 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0001581992
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:10 PM ET
- Size
- 7.0 KB